Statement of NIL deviation or variation in fund utilization
The announcement is a routine compliance update with no significant impact on the company's operations or financials.
The announcement is a compliance report indicating no deviation in fund utilization.
* Kabra Extrusiontechnik Limited reports no deviation or variation in the utilization of proceeds from preferential issue as stated in the placement document. * This statement pertains to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. * The report covers the quarter ended 30th June, 2025. Funds were raised through preferential issue of warrants and conversion of warrants to equity shares on various dates in 2022 and 2023. * A total of ₹101.01 crore was raised, and ₹100.90 crore has been utilized primarily for funding research and development and operating expenditure.
What to do with a filing like this
Kabra Extrusion Technik Limited filed this with the NSE as a statutory disclosure, categorised under regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kabra Extrusion Technik Limited. Read the original for the full detail.